Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | -8.16% |
|
-8.16% | -81.91% |
06-10 | Vivos Therapeutics, Inc. announced that it has received $7.5 million in funding | CI |
05-14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.91% | 7.26M | |
+75.69% | 12.57B | |
-25.35% | 7.28B | |
+15.77% | 7.2B | |
+14.52% | 5.47B | |
-18.50% | 4.73B | |
+14.91% | 4.09B | |
-23.67% | 3.78B | |
+42.93% | 2.3B | |
-0.37% | 2.03B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Earnings Flash (VVOS) VIVOS THERAPEUTICS Reports Q1 Revenue $3.9M, vs. Street Est of $4.01M